Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The dendritic cell plasma membrane is the specialized lipid bilayer that defines the boundary of dendritic cells (DCs), the most potent antigen-presenting cells of the immune system [Banchereau & Steinman, 1998, Nature]. It serves as the primary platform for immune surveillance, housing a vast array of receptors such as Toll-like receptors (TLRs), C-type lectin receptors (CLRs), and Major Histocompatibility Complex (MHC) molecules [Worbs et al., 2017, Nature Reviews Immunology]. These surface proteins enable the capture, processing, and presentation of antigens to T cells, a process fundamental to the initiation of adaptive immunity. In clinical applications, the membrane is the site of action for various immunotherapies, including DC-based vaccines and checkpoint inhibitors that target membrane-bound proteins like PD-L1 [Gardner et al., 2020, Frontiers in Immunology]. Although the membrane itself is a complex cellular compartment rather than a single therapeutic target, its unique protein composition is critical for diagnosing immune states and developing targeted therapies for cancer and autoimmune diseases. The dynamic nature of this membrane allows for the formation of the immunological synapse, which is essential for effective T cell activation. Furthermore, the membrane's lipid composition and fluidity play roles in the efficiency of endocytosis and signaling.
Not applicable; the dendritic cell plasma membrane is a cellular structure containing multiple distinct molecular targets rather than being a single therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cell plasma membrane.